Oruka Therapeutics, Inc. ORKA Increase Decrease In Other Accounts Payable
Increase Decrease In Other Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayable.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s increase decrease in other accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s increase decrease in other accounts payable?
- Oruka Therapeutics, Inc. (ORKA) reported increase decrease in other accounts payable of -$493K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s increase decrease in other accounts payable changed year-over-year?
- Oruka Therapeutics, Inc.'s increase decrease in other accounts payable decreased by 694.0% year-over-year, from $83K to -$493K.
- What does increase decrease in other accounts payable mean?
- Represents the net change in miscellaneous short-term obligations owed to suppliers or service providers not classified under primary accounts payable. This metric helps investors track fluctuations in working capital requirements and short-term liquidity management.